1. The anti-ischemic and anti-anginal properties of statins.
- Author
-
Lardizabal JA and Deedwania PC
- Subjects
- Angina Pectoris etiology, Angina Pectoris metabolism, Angina Pectoris physiopathology, Animals, Clinical Trials as Topic, Coronary Vessels drug effects, Coronary Vessels pathology, Endothelium, Vascular metabolism, Endothelium, Vascular physiopathology, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors administration & dosage, Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects, Inflammation metabolism, Lipoproteins, LDL metabolism, Myocardial Ischemia complications, Myocardial Ischemia metabolism, Myocardial Ischemia physiopathology, Plaque, Atherosclerotic metabolism, Plaque, Atherosclerotic physiopathology, Reperfusion Injury etiology, Reperfusion Injury metabolism, Reperfusion Injury physiopathology, Treatment Outcome, Vasodilation drug effects, Angina Pectoris drug therapy, Endothelium, Vascular drug effects, Inflammation drug therapy, Myocardial Ischemia drug therapy, Plaque, Atherosclerotic drug therapy, Reperfusion Injury prevention & control
- Abstract
Angina pectoris resulting from myocardial ischemia afflicts half of all patients with coronary heart disease (CHD). Chronic angina remains a major public health burden despite state-of-the-art therapies, and improvement in survival from myocardial infarction and CHD has only increased its prevalence. There is growing experimental and clinical evidence pointing to the anti-ischemic and anti-anginal properties of statins. Some data suggest that the degree of anti-ischemic efficacy of statins may be comparable to the current standard pharmacologic and mechanical strategies. The pleiotropic effects of statins are postulated to be primarily responsible for their anti-ischemic and anti-anginal properties. These include improvement of endothelial function, enhancement of the ischemic vasodilatory response, modulation of inflammation, and protection from ischemia-reperfusion injury. The anti-ischemic effects of statins further strengthen their role as a crucial component of the optimal medical therapy for CHD.
- Published
- 2011
- Full Text
- View/download PDF